DNMT3A-R882 mutation promotes acute myeloid leukemia progression by recruiting E2H2 to inhibit circKCNQ5 methylation
{{output}}
Background: Patients with acute myeloid leukemia (AML) harboring the DNMT3A-R882 mutation (DR882MUT) are often more difficult to treat and more likely to relapse. However, whether DR882MUT modulates AML progression via circRNAs r... ...
